Spinofix, Inc Poised for Growth or Acquisition. Stand-Alone, Low Cost Spine Fixation Technology

Spinofix, Inc Poised for Growth or Acquisition.

Stand-Alone, Low Cost Spine Fixation Technology  

Irvine, CA Dec 21, 2012 – Spinofix, Inc., a medical device company focused on providing next generation, low cost stand-alone alternatives to traditional spinal fusion, today announced that it is ready for growth capital or acquisition. Spinofix has researched the US and international markets which includes China, Taiwan, India, Middle East, Europe and Latin America.

90 Percent of the spine fusion surgery internationally and 80 percent of US market is open fixation procedures. Spinofix has come up with innovative devices to treat  patients with less hardware and provide substantially equivalent fixation. Product is going through the testing process. Company received its ISO 13485 certification Q2 of 2012 and hoping to get a CE mark in a few months.

“We are pleased to reach this significant milestone and inquiries from companies to acquire the technology now” said Glenn Morimoto, Chief Marketing & Sales Officer of Spinofix, Inc. “We are poised for growth or acquisition, this could be a larger company or even a Private Equity play, we are open to options that makes sense to us”. “Spinofix system has experienced tremendous response from worldwide surgeons and we look forward to achieving FDA approval in the US” said Morimoto.

 “The cross connector systems  is an exciting option for spine surgeons performing lumbar fusion surgery as it can create immediate stability and fixation once it’s properly positioned.” says Dr. Brian Pariera from the Bay Area.  “The unique design of Spinofix products is intriguing and can attract surgeons if displayed at a spine convention or get the sales representative’s foot in the door, that itself is a opportunity for an exit” said Mr David Luvisa, Managing Director at HunterWise Financial, who has been successful in Spine company transaction. “In spine industry we all know, that metals drive biologics, there are some biologic companies who don’t have a spine fixation product, this may be the differentiating technology to acquire before international players grab the opportunity or it becomes too expensive.” said Luvisa.
Spinofix, Inc is located in Irvine, Ca and one of the innovative companies with a small team and aggressive strategy to bring a next generation technology to the conventional spine surgery market. www.spinofix.com